IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Hungary

  • ID: 1408484
  • Report
  • Region: Hungary
  • 50 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

Hungary

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Healthcare Provision
  • Reorganisation
  • Funding

2. Pricing

  • Prescription Drugs
  • Application
  • Assessment
  • Listing Agreements
  • Timelines
  • Generic Drugs
  • Generics
  • Biosimilars
  • Hospital Drugs
  • Procurement
  • Hospital Debts
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Basic Criteria
  • Standard and Simplified Procedures
  • Application
  • Assessment
  • Decision
  • Appeals
  • Timelines
  • Beneficiary Status Reimbursement
  • Individual Reimbursement
  • Reimbursement Categories
  • Normative Reimbursement
  • Indication-bound Reimbursement
  • Other Categories
  • Reimbursement Prices
  • Active Ingredient Reference Pricing
  • Therapeutic Reference Pricing
  • Biological Drug Reference Pricing
  • Reference Price System Updates
  • Hospital Reimbursement
  • Formularies
  • Funding
  • Changes in Reimbursement Status
  • Delisting
  • Reimbursement Categories
  • Changes in Reimbursement Prices
  • Price Increase/Reductions
  • Price Reviews
  • Reference Pricing System Updates
  • Quarterly Updates
  • Twice-yearly Updates

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • Overview
  • Procedure
  • Decision

5. Price Build Up

  • Wholesalers
  • Margins
  • Rebate
  • Background
  • Retail Pharmacies
  • Margins
  • Additional Fees
  • Background
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Budget Excess Repayments
  • Clawback
  • Additional Clawback
  • Pharmaceutical Sales Representative Fee
  • Promotional Costs
  • Advertising
  • Sales Representatives
  • Payments to Healthcare Professionals
  • Codes of Conduct
  • Patient Co-payments
  • Pharmaceuticals
  • Healthcare
  • Prescribing Controls
  • Prescription Feedback
  • Traffic Light System
  • Prescribing Guidelines
  • Prescribing Restrictions
  • Prescribing Quotas
  • Indication-bound Reimbursement
  • INN Prescribing
  • E-health
  • Generics
  • Generic Substitution
  • Generic Dispensing Incentives
  • INN Prescribing
  • Incentives for Patients
  • Biosimilars
  • Rx-to-OTC Switches
  • Parallel Trade

7. Future Developments

  • Outlook
  • Budget Excess Repayments
  • E-Health System
  • Hospital Management

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll